Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion

NCT03751423 is registered in ClinicalTrials.gov with Dr. Marie Eve Sophie Bussiere-Cote as lead sponsor.

NCT NCT03751423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03751423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion
Lead sponsor
Dr. Marie Eve Sophie Bussiere-Cote
Phase
Phase 3
Overall status
Suspended
Start date
June 10, 2019
Completion date
December 31, 2023
Enrollment
123 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion in first trimester